Targeted Drug Shows Promise Against Advanced Kidney Cancer
Nearly doubles progression-free survival to 7.4 months, but side effects reported, study showsContinue Reading
Nearly doubles progression-free survival to 7.4 months, but side effects reported, study showsContinue Reading
In some states, rate is as low as 1 percent, study findsContinue Reading
Study found this type of treatment helped many overcome phobias about dental visitsContinue Reading
Here are possible warning signs
Continue Reading
Study finds many survivors have no symptoms, but still have heart problemsContinue Reading
Analysis indicates ACE inhibitors and ARBs are equally effective, researchers sayContinue Reading
Drugs to counter biological or other threats too often geared to adults, American Academy of Pediatrics saysContinue Reading
Experts say experimenting with longer times between washing is a personal choiceContinue Reading
Getting levels below current targets may significantly cut risk of heart attack, stroke, researchers contendContinue Reading
Disturbing images get people thinking about health risks associated with tobacco, study findsContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.